Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2010 1
2012 1
2017 5
2018 3
2020 1
2022 1
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Practical Approach to Initiating SGLT2 Inhibitors in Type 2 Diabetes.
Gomez-Peralta F, Abreu C, Lecube A, Bellido D, Soto A, Morales C, Brito-Sanfiel M, Umpierrez G. Gomez-Peralta F, et al. Among authors: brito sanfiel m. Diabetes Ther. 2017 Oct;8(5):953-962. doi: 10.1007/s13300-017-0277-0. Epub 2017 Jul 18. Diabetes Ther. 2017. PMID: 28721687 Free PMC article. Review.
Economic impact of hypoglycemia on healthcare in Spain.
Brito-Sanfiel M, Diago-Cabezudo J, Calderon A. Brito-Sanfiel M, et al. Expert Rev Pharmacoecon Outcomes Res. 2010 Dec;10(6):649-60. doi: 10.1586/erp.10.73. Expert Rev Pharmacoecon Outcomes Res. 2010. PMID: 21155698 Review.
Real-world safety and effectiveness of dapagliflozin in people living with type 1 diabetes in Spain: The Dapa-ON multicenter retrospective study.
Durán-Martínez M, Azriel S, Doulatram-Gamgaram VK, Moreno-Pérez Ó, Pinés-Corrales PJ, Tejera-Pérez C, Merino-Torres JF, Brito-Sanfiel M, Chico A, Marco A, García-Fernández E, Martínez-Montoro JI; Diabetes Area of the Spanish Society of Endocrinology and Nutrition (SEEN). Durán-Martínez M, et al. Among authors: brito sanfiel m. Diabetes Metab. 2024 Jan;50(1):101501. doi: 10.1016/j.diabet.2023.101501. Epub 2023 Dec 5. Diabetes Metab. 2024. PMID: 38061425 Free article.
Physical activity patterns in type 1 diabetes in Spain: The SED1 study.
Gómez-Peralta F, Menéndez E, Conde S, Conget I, Novials A; SED and SED1 study investigators. Gómez-Peralta F, et al. BMC Sports Sci Med Rehabil. 2023 Jul 26;15(1):92. doi: 10.1186/s13102-023-00695-3. BMC Sports Sci Med Rehabil. 2023. PMID: 37491278 Free PMC article.
Effectiveness and Tolerability of the Intensification of Canagliflozin Dose from 100 mg to 300 mg Daily in Patients with Type 2 Diabetes in Real Life: The INTENSIFY Study.
Gorgojo-Martinez JJ, Ferreira-Ocampo PJ, Galdón Sanz-Pastor A, Cárdenas-Salas J, Antón-Bravo T, Brito-Sanfiel M, Almodóvar-Ruiz F. Gorgojo-Martinez JJ, et al. Among authors: brito sanfiel m. J Clin Med. 2023 Jun 25;12(13):4248. doi: 10.3390/jcm12134248. J Clin Med. 2023. PMID: 37445283 Free PMC article.
Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients.
Ridker PM, Revkin J, Amarenco P, Brunell R, Curto M, Civeira F, Flather M, Glynn RJ, Gregoire J, Jukema JW, Karpov Y, Kastelein JJP, Koenig W, Lorenzatti A, Manga P, Masiukiewicz U, Miller M, Mosterd A, Murin J, Nicolau JC, Nissen S, Ponikowski P, Santos RD, Schwartz PF, Soran H, White H, Wright RS, Vrablik M, Yunis C, Shear CL, Tardif JC; SPIRE Cardiovascular Outcome Investigators. Ridker PM, et al. N Engl J Med. 2017 Apr 20;376(16):1527-1539. doi: 10.1056/NEJMoa1701488. Epub 2017 Mar 17. N Engl J Med. 2017. PMID: 28304242 Free article. Clinical Trial.
Erratum to: Practical Approach to Initiating SGLT2 Inhibitors in Type 2 Diabetes.
Gomez-Peralta F, Abreu C, Lecube A, Bellido D, Soto A, Morales C, Brito-Sanfiel M, Umpierrez G. Gomez-Peralta F, et al. Among authors: brito sanfiel m. Diabetes Ther. 2017 Oct;8(5):963-965. doi: 10.1007/s13300-017-0290-3. Diabetes Ther. 2017. PMID: 28836177 Free PMC article. No abstract available.
16 results